These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19958061)

  • 1. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
    Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
    Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
    Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
    Niguma T; Mimura T; Tutui N
    J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma.
    Ueshima K; Kudo M; Takita M; Nagai T; Tatsumi C; Ueda T; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Minami Y; Chung H
    Oncology; 2010 Jul; 78 Suppl 1():148-53. PubMed ID: 20616598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Furuse J; Mitsunaga S; Ueno H; Yamaura H; Inaba Y; Takeuchi Y; Satake M; Arai Y
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):463-70. PubMed ID: 23812005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Sim MK; Kim DY; Park JY; Kim JK; Kim SA; Ahn SH; Chon CY; Moon YM; Won JY; Lee DY; Han KH
    Korean J Hepatol; 2005 Sep; 11(3):268-74. PubMed ID: 16177553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
    Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
    Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH
    Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
    Nagano H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Tomimaru Y; Osuga K; Umeshita K; Doki Y; Mori M
    Oncology; 2011; 80(1-2):63-9. PubMed ID: 21659784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
    Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
    Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
    Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.